Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Conditions

• Acute Myeloid Leukemia in Remission

Interventions

• OTHER: Prospective determination of the clinical utility of measurable residual disease (MRD) testing

Sponsor

Center for International Blood and Marrow Transplant Research

Collaborators

• [object Object]